S 526
Pharmacy Benefit Manager Transparency Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 7:57 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The Pharmacy Benefit Manager Transparency Act of 2025 aims to increase transparency and accountability in how pharmacy benefit managers (PBMs) operate. It prohibits certain unfair practices, such as arbitrarily reducing reimbursements to pharmacies or charging different prices to health plans. The bill also requires PBMs to report detailed information about their pricing and fee structures to the Federal Trade Commission and Congress, and establishes whistleblower protections for individuals reporting potential violations. Finally, it addresses potential conflicts of interest and promotes competition within the pharmaceutical supply chain.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.